Updated use of aminoquinolines for the treatment of COVID-19.

Abstract

Due to the current pandemic produced by the SARS-CoV-2, there has been a scientific race in order to find an appropriate treatment and prophylaxis for patients with COVID-19. Multiple studies in the literature have shown that chloroquine and hydroxychloroquine inhibits the virus in vitro. However the majority of the in vivo data comes from observational studies, some of these with severe flaws in their study design. It's important to make conclusions based on the results of the randomized controlled trials that are underway.

• Authors: Héctor Hugo ArredondoNiño
• Journal: Revista medica del Instituto Mexicano del Seguro Social (Rev Med Inst Mex Seguro Soc) Vol. 58 Issue Supl 2 Pg. S309-311 (09 21 2020) ISSN: 2448-5667 [Electronic] Mexico
• Vernacular Title: Uso actual de las aminoquinolinas para el tratamiento de la COVID-19.
• PMID: 34695344 (Publication Type: Journal Article)
• Copyright: Copyright: © 2020 Revista Medica del Instituto Mexicano del Seguro Social.